Alternative Cancer Cures: “Unproven” or “Disproven”?

@article{Vickers2004AlternativeCC,
  title={Alternative Cancer Cures: “Unproven” or “Disproven”?},
  author={Andrew Julian Vickers},
  journal={CA: A Cancer Journal for Clinicians},
  year={2004},
  volume={54}
}
  • A. Vickers
  • Published 1 March 2004
  • Medicine
  • CA: A Cancer Journal for Clinicians
Oncology has always coexisted with therapies offered outside of conventional cancer treatment centers and based on theories not found in biomedicine. These alternative cancer cures have often been described as “unproven,” suggesting that appropriate clinical trials have not been conducted and that the therapeutic value of the treatment is unknown. Contrary to much popular and scientific writing, many alternative cancer treatments have been investigated in good quality clinical trials, and they… 

Le terapie non convenzionali in oncologia

: Although alternative and complementary therapies are a well known, spread reality, and many alternative cancer cure were generally found ineffective in clinical trials, oncologists don't care of

Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Complementary therapies have an increasingly important role in the control of symptoms associated with cancer and cancer treatment and should be investigated for side effects and potential interactions with chemotherapy and other medications.

Alternative Medicine in Children with Cancer – Facts and Myths

Current knowledge about most frequently used CAM methods in children with cancer, its prevalence and effects of use, and a summary of current knowledge about scientific analysis are summarized.

A Review: Comprehensive Study on Anticancer Therapy

Cancer known medically as a malignant neoplasm, is a broad group of diseases involving unregulated cell growth, which is primarily an environmental disease with 90–95% of cases attributed to environmental factors and 5–10% due to genetics.

Complementary and alternative (CAM) dietary therapies for cancer

There is no evidence to support the claims that CAM dietary therapies cure cancer and the potential advantages and disadvantages of CAM diets are discussed.

Prevention and treatment of cancer cachexia: new insights into an old problem.

The “therapeutic footprint” of medical, complementary and alternative therapies and a doctorˈs duty of care

Understanding the difference between complementary and alternative therapies and how they differ from standard medical care helps doctors whose patients are using complementary or alternative therapies to define the boundaries between these therapies and professional medicine and provide appropriate disclosure of risks.

Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study

Breast cancer patients receiving prophylactic acupuncture during chemotherapy did not show better quality of life in the questionnaires in contrast to the reported positive effects in the qualitative interviews, but coping strategies for cancer appear to be important.

Acupuncture and Moxibustion as an Evidence-based Therapy for Cancer

It was concluded that CINV and cancer pain are the only indications for acupuncture, acupressure or moxibustion currently supported by concrete evidence and future studies should be of high quality with a particular emphasis on designing adequate control interventions.
...

References

SHOWING 1-10 OF 59 REFERENCES

Alternative cancer cures

  • E. Ernst
  • Medicine
    British Journal of Cancer
  • 2001
This short article is aimed at enhancing oncologists’ understanding of complementary and alternative medicine (CAM), where a charismatic individual who claims to have found the answer to cancer gathers ardent supporters who lobby for a wider acceptance of this ACC.

Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy

  • Medicine
    BMJ
  • 1999
Di Bella multitherapy did not show sufficient efficacy in patients with advanced cancer to warrant further clinical testing, and toxicity was evaluated using criteria developed by the World Health Organisation.

Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer.

Under the specific conditions of this study, SC as a single agent was inactive in patients with advanced-stage cancer and had no salutary effect on quality of life.

Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy.

The length of survival and quality of life in patients who received treatment at a prominent unorthodox cancer clinic in addition to conventional treatment and in matched control patients from an academic cancer center who received only conventional treatment were compared.

A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.

Amygdalin (Laetrile) is a toxic drug that is not effective as a cancer treatment and patients exposed to this agent should be instructed about the danger of cyanide poisoning, and their blood cyanide levels should be carefully monitored.

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.

This trial failed to demonstrate any benefit for patients who received hydrazine sulfate and no significant differences were noted in the two study arms with regard to toxicity or quality of life (QL).

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.

This trial failed to demonstrate any benefit for hydrazine sulfate in cancer patients and showed trends both for poorer survival and for poorer quality of life (QL) in the Hydrazine group.

Assessment of outcomes at alternative medicine cancer clinics: a feasibility study.

Historical, widespread use of clinics such as these with anecdotal reports of extraordinary survival merit prospective, systematic monitoring of patient outcomes, however, disease status must be pathologically confirmed and patient follow-up improved.
...